MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 8.587
EU - Europa 3.377
AS - Asia 1.882
OC - Oceania 20
SA - Sud America 19
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.893
Nazione #
US - Stati Uniti d'America 8.507
IT - Italia 1.680
CN - Cina 784
SG - Singapore 550
UA - Ucraina 506
DE - Germania 337
TR - Turchia 307
GB - Regno Unito 257
FI - Finlandia 133
RO - Romania 110
SE - Svezia 106
ID - Indonesia 102
CA - Canada 70
FR - Francia 52
PL - Polonia 41
BE - Belgio 32
NL - Olanda 31
IN - India 26
CZ - Repubblica Ceca 23
JP - Giappone 22
AU - Australia 19
HK - Hong Kong 17
IR - Iran 17
ES - Italia 14
RU - Federazione Russa 14
BR - Brasile 10
LT - Lituania 10
CH - Svizzera 9
PK - Pakistan 9
UZ - Uzbekistan 9
HU - Ungheria 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
VN - Vietnam 6
MX - Messico 5
PT - Portogallo 5
CL - Cile 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
IL - Israele 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IE - Irlanda 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 13.893
Città #
Fairfield 1.078
Woodbridge 978
Ashburn 628
Chandler 604
Houston 589
Jacksonville 539
Singapore 438
Seattle 410
Ann Arbor 393
Wilmington 388
Cambridge 378
Santa Clara 374
Ferrara 246
Beijing 193
Izmir 193
Princeton 158
Milan 157
Nanjing 141
Shanghai 133
Boardman 110
San Diego 107
Jakarta 94
New York 89
Redwood City 68
Rome 59
Los Angeles 50
Bologna 44
Bremen 43
Hebei 42
Shenyang 40
Falls Church 36
Helsinki 36
Warsaw 32
London 29
Brussels 27
Nanchang 27
Norwalk 27
Tianjin 27
Mountain View 26
Washington 26
Jiaxing 25
Cagliari 22
San Mateo 22
Changsha 20
Ottawa 20
Toronto 20
Auburn Hills 19
Brno 19
Florence 18
Leawood 18
Munich 16
Dearborn 14
Hong Kong 14
Augusta 13
Jinan 13
Ardabil 12
Zhengzhou 12
Kunming 11
Frankfurt am Main 10
Redmond 10
Tokyo 10
Venice 10
Clifton Park 9
Guangzhou 9
Palermo 9
San Jose 9
Serra 9
Tappahannock 9
Catania 8
Guarda Veneta 8
Mississauga 8
Naples 8
Padova 8
Taizhou 8
Tashkent 8
Timisoara 8
Turin 8
Verona 8
Winchester 8
Amsterdam 7
Brescia 7
Chicago 7
Falkenstein 7
Indiana 7
Minerbe 7
Ningbo 7
Orange 7
Pune 7
Daly City 6
Dong Ket 6
Modena 6
Salt Lake City 6
Adelaide 5
Bandung 5
Brusaporto 5
Charlton 5
Dubai 5
Ferrara di Monte Baldo 5
Genoa 5
Haikou 5
Totale 9.674
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 638
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 368
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 301
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 236
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 190
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 186
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 185
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 168
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 154
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 150
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 149
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 148
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 144
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 141
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 133
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 131
Loss of cortical GABA terminals in Unverricht–Lundborg disease 130
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 129
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 128
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 127
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 126
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 124
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 124
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 123
null 121
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 120
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 120
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 118
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 118
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 115
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 115
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 115
JWH-018 impairs sensorimotor functions in mice 115
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 114
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 114
null 113
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 113
Un distillato Bohémienne tuttora famoso: l’assenzio 113
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 112
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 112
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 112
Antagonisti dei recettori NOP e loro usi terapeutici 111
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 111
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 111
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 109
null 108
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 108
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 107
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 105
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 104
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 103
Novel Synthetic Opioids: The Pathologist's Point of View 98
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata: A microdialysis study in the awake freely moving rat. 97
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 95
null 94
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat. 93
null 92
null 92
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 92
null 91
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 90
null 89
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 89
Cutaneous miRNAs expression in human hanging injuries 89
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 89
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 88
null 88
Ayahuasca: il vino dell'anima 88
null 87
null 87
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 86
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 86
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 85
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 85
null 84
Application of 13 loci STR multiplex for the cannabis sativa genotyping 83
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 82
null 82
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 82
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 82
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 81
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 81
Reply to "MDPV-induced aggression in humans not established" 81
Droghe da stupro: il GHB ed i suoi analoghi 79
Application of 13 loci STR multiplex for cannabis sativa genotyping 79
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 79
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 77
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 77
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 76
DNA recovery from immunochromatographic membranes 74
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 73
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 69
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 67
Mrna profiling in casework analyses 67
Nociceptin/orphanin FQ receptor antagonists reverse parkinsonism in MPTP-treated mice and non-human primates 66
Studio multidisciplinare degli effetti farmaco-tossicologici e fisiopatologici di nuove molecole psicoattive sintetiche (novel synthetic drugs, ns-drugs) per comprendere le possibili alterazioni psico-fisiche nei guidatori di autoveicoli 66
Reciprocal dopamine-glutamate modulation of release in the basal ganglia 65
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 64
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 64
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 63
Totale 11.483
Categoria #
all - tutte 70.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 843
Totale 71.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.584 0 0 0 0 152 252 206 245 229 245 190 65
2020/20212.265 179 137 190 247 165 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/20251.760 206 174 532 318 530 0 0 0 0 0 0 0
Totale 14.195